Toby A Maurer, MD
Dermatology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 5 carriers
- Offices
- 4
Offices
4 locations · County of San Mateo · Bay Area Community Health
Looking this up.
Hospitals listed: San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
20 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Maurer’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A45876 · Current
Licensed to practise in California · since 1989 · expires 2028-04-30 · University of Calgary Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 26 | More than 67% of doctors who do this |
| Skin biopsy | 1-10 | None |
Year by year
| 2022 | 16 | 60 | 66 | 1.10 | $8,642 | $1,220 |
| 2021 | 14 | 42 | 72 | 0.93 | $8,536 | $1,392 |
| 2019 | 96 | 184 | 75 | 1.84 | $58,603 | $4,967 |
| 2018 | 154 | 380 | 75 | 1.90 | $105,601 | $10,380 |
| 2017 | 217 | 631 | 74 | 1.71 | $137,189 | $14,768 |
| 2016 | 243 | 721 | 73 | 1.95 | $149,657 | $17,931 |
| 2015 | 142 | 281 | 72 | 1.88 | $63,351 | $6,868 |
| 2014 | 203 | 672 | 74 | 1.83 | $154,968 | $18,301 |
| 2013 | 198 | 556 | 74 | 1.90 | $131,935 | $17,798 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 5 services
| Short return visit (20+ min) | 47 | $2,820 | $38 |
| Destruction of precancer skin growth, 1 growth | 17 | $659 | $35 |
| Short return visit | 20 | $412 | $19 |
| New patient visit (15+ min) | 12 | $319 | $27 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $59 | $2 |
2018: 5 services
| Short return visit (20+ min) | 84 | $6,220 | $41 |
| Destruction of precancer skin growth, 1 growth | 28 | $1,260 | $35 |
| New patient visit (15+ min) | 13 | $538 | $41 |
| Short return visit | 26 | $499 | $16 |
| Destruction of precancer skin growth, 2-14 growths | 22 | $163 | $1 |
2017: 9 services
| Short return visit (20+ min) | 83 | $6,650 | $39 |
| Destruction of precancer skin growth, 1 growth | 33 | $2,084 | $44 |
| Destruction of precancer skin growth, 1 growth | 24 | $1,130 | $43 |
| Short return visit | 39 | $999 | $21 |
| New patient visit (15+ min) | 26 | $941 | $36 |
| Short return visit (20+ min) | 11 | $442 | $40 |
| New patient visit (15+ min) | 12 | $366 | $30 |
| Destruction of precancer skin growth, 2-14 growths | 26 | $271 | $2 |
| Destruction of precancer skin growth, 2-14 growths | 20 | $177 | $2 |
2016: 10 services
| Short return visit (20+ min) | 91 | $7,278 | $41 |
| Destruction of precancer skin growth, 1 growth | 42 | $2,458 | $43 |
| Destruction of precancer skin growth, 1 growth | 24 | $1,232 | $47 |
| New patient visit (15+ min) | 28 | $1,227 | $44 |
| New patient visit (15+ min) | 22 | $937 | $43 |
| Short return visit | 37 | $863 | $17 |
| Biopsy of single growth of skin and/or tissue | 22 | $821 | $34 |
| Short return visit | 20 | $387 | $18 |
| Destruction of precancer skin growth, 2-14 growths | 35 | $364 | $2 |
| Destruction of precancer skin growth, 2-14 growths | 19 | $115 | $2 |
2015: 5 services
| Short return visit (20+ min) | 68 | $3,235 | $33 |
| Destruction of precancer skin growth, 1 growth | 23 | $934 | $39 |
| New patient visit (15+ min) | 22 | $867 | $39 |
| Short return visit | 30 | $547 | $18 |
| Destruction of precancer skin growth, 2-14 growths | 18 | $131 | $2 |
2014: 7 services
| Short return visit (20+ min) | 111 | $9,744 | $39 |
| Destruction of precancer skin growth, 1 growth | 47 | $2,454 | $40 |
| Cold treatment of acne | 19 | $1,221 | $42 |
| New patient visit (15+ min) | 30 | $1,175 | $39 |
| Biopsy of single growth of skin and/or tissue | 24 | $860 | $34 |
| Short return visit | 29 | $761 | $20 |
| Destruction of precancer skin growth, 2-14 growths | 36 | $385 | $2 |
2013: 6 services
| Short return visit (20+ min) | 133 | $11,121 | $39 |
| Destruction of precancer skin growth, 1 growth | 39 | $2,170 | $41 |
| New patient visit (15+ min) | 29 | $1,073 | $37 |
| Biopsy of single growth of skin and/or tissue | 16 | $678 | $38 |
| Destruction of precancer skin growth, 2-14 growths | 29 | $412 | $3 |
| Short return visit | 17 | $346 | $19 |
Medicaid work
$149,063 in 2024
Medicaid paid $149,063 for 1,604 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 434 | $120,408 |
| Return visit (30+ min) | 986 | $14,344 |
| Short return visit (20+ min) | 130 | $8,858 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 29 | $4,227 |
| Injection, intralesional; up to and including 7 lesions | 13 | $616 |
| Short return visit | 12 | $609 |
| 2024 | 1,604 | 6 | 99 | $149,063 |
| 2023 | 1,288 | 4 | 46 | $109,519 |
| 2022 | 331 | 4 | 17 | $24,667 |
| 2021 | 921 | 3 | 36 | $71,775 |
| 2020 | 561 | 3 | 37 | $53,017 |
| 2019 | 91 | 4 | 24 | $11,493 |
| 2018 | 269 | 4 | 17 | $17,712 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 340 | $90,737 |
| Return visit (30+ min) | 772 | $10,849 |
| Short return visit (20+ min) | 148 | $5,479 |
| New patient visit (30+ min) | 28 | $2,456 |
2022
| Clinic visit/encounter, all-inclusive | 71 | $17,427 |
| Return visit (30+ min) | 177 | $3,624 |
| Short return visit (20+ min) | 70 | $2,406 |
| New patient visit (30+ min) | 13 | $1,211 |
2021
| Clinic visit/encounter, all-inclusive | 264 | $63,917 |
| Short return visit (20+ min) | 627 | $6,275 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 30 | $1,583 |
2020
| Clinic visit/encounter, all-inclusive | 218 | $52,199 |
| Short return visit (20+ min) | 314 | $784 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 29 | $34 |
2019
| Clinic visit/encounter, all-inclusive | 42 | $11,455 |
| Short return visit | 15 | $38 |
| Short return visit (20+ min) | 19 | $0 |
| Hospital outpatient clinic visit for assessment and management of a patient | 15 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 56 | $16,859 |
| Service | 25 | $853 |
| Short return visit (20+ min) | 103 | $0 |
| Hospital outpatient clinic visit for assessment and management of a patient | 85 | $0 |
Drugs they prescribed that Part D paid
$295,391
Pharmacies billed $295,391 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 321) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
263 generic and 58 brand-name prescriptions · $295,391 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 21 | $110,738 | $5,273 |
| Humira(Cf) | 16 | $107,581 | $6,724 |
| Clobetasol Propionate | 48 | $1,673 | $35 |
| Triamcinolone Acetonide | 33 | $437 | $13 |
| Fluocinonide | 15 | $427 | $28 |
See all 8 drugs
| Dupixent | 21 | $110,738 | $5,273 |
| Humira(Cf) | 16 | $107,581 | $6,724 |
| Clobetasol Propionate | 48 | $1,673 | $35 |
| Triamcinolone Acetonide | 33 | $437 | $13 |
| Fluocinonide | 15 | $427 | $28 |
| Ciclopirox | 16 | $425 | $27 |
| Ketoconazole | 32 | $423 | $13 |
| Methotrexate | 12 | $256 | $21 |
Year by year
| 2024 | 321 | 95 | 0% (0) | 18% | $295,391 |
| 2023 | 312 | 81 | 0% (0) | 6% | $83,859 |
| 2022 | 241 | 58 | 0% (0) | 9% | $111,524 |
| 2021 | 282 | 76 | 0% (0) | 6% | $48,993 |
| 2020 | 138 | 45 | 0% (0) | 9% | $7,131 |
| 2019 | 484 | 122 | 0% (0) | 12% | $42,253 |
| 2018 | 734 | 160 | 0% (0) | 14% | $115,607 |
| 2017 | 818 | 194 | 0% (0) | None | $98,045 |
| 2016 | 1,282 | 276 | None | None | $160,333 |
| 2015 | 1,867 | 410 | None | 12% | $244,046 |
| 2014 | 1,680 | 323 | 0% (0) | 11% | $122,967 |
| 2013 | 1,255 | 200 | None | 10% | $97,750 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Clobetasol Propionate | 27 | $2,968 | $110 |
| Triamcinolone Acetonide | 56 | $1,210 | $22 |
| Fluocinonide | 13 | $736 | $57 |
| Methotrexate | 18 | $619 | $34 |
| Ketoconazole | 23 | $547 | $24 |
| Ciclopirox | 11 | $394 | $36 |
| Minoxidil | 12 | $250 | $21 |
| Terbinafine | 11 | $243 | $22 |
| Doxepin | 14 | $218 | $16 |
| Prednisone | 11 | $94 | $9 |
2022: 5 drugs
| Humira(Cf) | 14 | $88,565 | $6,326 |
| Fluocinonide | 27 | $2,926 | $108 |
| Ketoconazole | 53 | $1,348 | $25 |
| Triamcinolone Acetonide | 37 | $808 | $22 |
| Prednisone | 13 | $126 | $10 |
2021: 6 drugs
| Fluocinonide | 28 | $1,627 | $58 |
| Doxycycline Hyclate | 13 | $1,377 | $106 |
| Clobetasol Propionate | 24 | $1,092 | $45 |
| Ketoconazole | 36 | $1,011 | $28 |
| Triamcinolone Acetonide | 56 | $846 | $15 |
| Prednisone | 15 | $145 | $10 |
2020: 3 drugs
| Ketoconazole | 21 | $467 | $22 |
| Triamcinolone Acetonide | 25 | $373 | $15 |
| Doxepin | 11 | $154 | $14 |
2019: 14 drugs
| Halobetasol Propionate | 41 | $5,829 | $142 |
| Tacrolimus | 21 | $5,249 | $250 |
| Desonide | 25 | $2,765 | $111 |
| Clobetasol Propionate | 20 | $2,713 | $136 |
| Econazole Nitrate | 18 | $2,612 | $145 |
| Ketoconazole | 67 | $2,143 | $32 |
| Acitretin | 13 | $1,642 | $126 |
| Betamethasone Dipropionate | 17 | $1,555 | $91 |
| Triamcinolone Acetonide | 74 | $1,244 | $17 |
| Alclometasone Dipropionate | 20 | $1,077 | $54 |
| Erythromycin | 11 | $486 | $44 |
| Terbinafine | 11 | $210 | $19 |
| Prednisone | 16 | $97 | $6 |
| Mometasone Furoate | 11 | $72 | $7 |
2018: 17 drugs
| Halobetasol Propionate | 40 | $6,227 | $156 |
| Elidel | 16 | $5,308 | $332 |
| Tacrolimus | 20 | $4,172 | $209 |
| Fluocinonide | 38 | $3,961 | $104 |
| Ketoconazole | 103 | $3,586 | $35 |
| Econazole Nitrate | 24 | $3,445 | $144 |
| Clobetasol Propionate | 28 | $3,320 | $119 |
| Triamcinolone Acetonide | 131 | $2,637 | $20 |
| Desonide | 11 | $2,022 | $184 |
| Alclometasone Dipropionate | 25 | $1,961 | $78 |
| Calcipotriene | 14 | $1,732 | $124 |
| Betamethasone Dipropionate | 13 | $1,397 | $107 |
| Clindamycin Phosphate | 11 | $583 | $53 |
| Terbinafine | 26 | $371 | $14 |
| Prednisone | 78 | $361 | $5 |
| Mometasone Furoate | 13 | $147 | $11 |
| Cephalexin | 13 | $121 | $9 |
2017: 17 drugs
| Clobetasol Propionate | 76 | $15,773 | $208 |
| Acitretin | 15 | $10,693 | $713 |
| Fluocinonide | 64 | $9,004 | $141 |
| Tacrolimus | 33 | $8,381 | $254 |
| Elidel | 20 | $5,956 | $298 |
| Calcipotriene | 31 | $4,709 | $152 |
| Desonide | 30 | $4,195 | $140 |
| Econazole Nitrate | 19 | $3,201 | $168 |
| Ketoconazole | 75 | $3,027 | $40 |
| Doxycycline Hyclate | 20 | $2,247 | $112 |
| Imiquimod | 12 | $1,693 | $141 |
| Triamcinolone Acetonide | 85 | $1,646 | $19 |
| Methotrexate | 13 | $793 | $61 |
| Terbinafine | 19 | $549 | $29 |
| Prednisone | 90 | $517 | $6 |
| Doxepin | 45 | $242 | $5 |
| Cephalexin | 26 | $226 | $9 |
2016: 21 drugs
| Clobetasol Propionate | 118 | $34,949 | $296 |
| Fluocinonide | 129 | $23,777 | $184 |
| Calcipotriene | 45 | $15,238 | $339 |
| Elidel | 28 | $7,020 | $251 |
| Ketoconazole | 122 | $6,521 | $53 |
| Desonide | 44 | $6,182 | $140 |
| Tacrolimus | 21 | $4,729 | $225 |
| Econazole Nitrate | 26 | $4,443 | $171 |
| Metronidazole | 26 | $4,375 | $168 |
| Doxycycline Hyclate | 25 | $3,815 | $153 |
| Triamcinolone Acetonide | 171 | $3,326 | $19 |
| Imiquimod | 25 | $2,766 | $111 |
| Tretinoin | 15 | $2,594 | $173 |
| Fluocinolone Acetonide | 12 | $2,134 | $178 |
| Fluorouracil | 11 | $1,534 | $139 |
| Prednisone | 98 | $565 | $6 |
| Doxepin | 94 | $498 | $5 |
| Hydrocortisone | 33 | $273 | $8 |
| Terbinafine | 22 | $252 | $11 |
| Cephalexin | 18 | $145 | $8 |
| Hydroxyzine | 20 | $135 | $7 |
2015: 31 drugs
| Clobetasol Propionate | 166 | $56,601 | $341 |
| Fluocinonide | 153 | $19,836 | $130 |
| Calcipotriene | 54 | $17,906 | $332 |
| Econazole Nitrate | 67 | $13,736 | $205 |
| Desonide | 86 | $13,579 | $158 |
| Acitretin | 14 | $11,110 | $794 |
| Metronidazole | 52 | $10,258 | $197 |
| Elidel | 33 | $9,752 | $296 |
| Doxycycline Hyclate | 38 | $7,587 | $200 |
| Tacrolimus | 23 | $7,111 | $309 |
| Imiquimod | 32 | $6,499 | $203 |
| Fluocinolone Acetonide | 31 | $5,586 | $180 |
| Ketoconazole | 146 | $5,543 | $38 |
| Halobetasol Propionate | 23 | $5,000 | $217 |
| Triamcinolone Acetonide | 235 | $4,354 | $19 |
| Fluocinolone Acetonide | 13 | $1,911 | $147 |
| Tretinoin | 17 | $1,632 | $96 |
| Clindamycin Phosphate | 19 | $1,232 | $65 |
| Prednisone | 117 | $786 | $7 |
| Doxepin | 141 | $764 | $5 |
| Valacyclovir | 13 | $623 | $48 |
| Hydrocortisone | 72 | $525 | $7 |
| Clotrimazole | 13 | $399 | $31 |
| Doxycycline Monohydrate | 11 | $355 | $32 |
| Acyclovir | 18 | $227 | $13 |
| Terbinafine | 19 | $187 | $10 |
| Cephalexin | 19 | $185 | $10 |
| Spironolactone | 11 | $164 | $15 |
| Mupirocin | 13 | $126 | $10 |
| Hydroxyzine | 12 | $116 | $10 |
| Gabapentin | 32 | $100 | $3 |
2014: 28 drugs
| Acitretin | 22 | $19,485 | $886 |
| Desonide | 97 | $16,141 | $166 |
| Clobetasol Propionate | 166 | $14,890 | $90 |
| Fluocinonide | 122 | $9,443 | $77 |
| Calcipotriene | 23 | $8,616 | $375 |
| Fluocinolone Acetonide | 38 | $7,088 | $187 |
| Protopic | 13 | $5,607 | $431 |
| Elidel | 23 | $5,429 | $236 |
| Doxycycline Hyclate | 43 | $5,245 | $122 |
| Econazole Nitrate | 49 | $4,333 | $88 |
| Triamcinolone Acetonide | 185 | $3,758 | $20 |
| Ketoconazole | 133 | $3,527 | $27 |
| Imiquimod | 15 | $3,372 | $225 |
| Clindamycin Phosphate | 22 | $1,937 | $88 |
| Tretinoin | 13 | $1,110 | $85 |
| Prednisone | 229 | $779 | $3 |
| Doxepin | 165 | $744 | $5 |
| Methotrexate | 12 | $556 | $46 |
| Alclometasone Dipropionate | 14 | $517 | $37 |
| Hydrocortisone | 43 | $351 | $8 |
| Hydroxyurea | 13 | $272 | $21 |
| Clotrimazole | 11 | $267 | $24 |
| Mupirocin | 14 | $220 | $16 |
| Hydroxyzine | 27 | $212 | $8 |
| Gabapentin | 59 | $193 | $3 |
| Terbinafine | 16 | $174 | $11 |
| Cephalexin | 16 | $166 | $10 |
| Famotidine | 12 | $36 | $3 |
2013: 21 drugs
| Cellcept | 12 | $13,495 | $1,125 |
| Protopic | 27 | $8,092 | $300 |
| Imiquimod | 20 | $8,031 | $402 |
| Doxycycline Hyclate | 89 | $7,552 | $85 |
| Desonide | 48 | $7,173 | $149 |
| Fluocinonide | 91 | $4,449 | $49 |
| Clobetasol Propionate | 111 | $3,745 | $34 |
| Fluocinolone Acetonide | 27 | $2,866 | $106 |
| Colcrys | 27 | $2,774 | $103 |
| Triamcinolone Acetonide | 104 | $2,216 | $21 |
| Elidel | 11 | $1,994 | $181 |
| Ketoconazole | 94 | $1,746 | $19 |
| Econazole Nitrate | 34 | $1,018 | $30 |
| Fluocinolone Acetonide | 12 | $863 | $72 |
| Prednisone | 182 | $483 | $3 |
| Doxepin | 98 | $407 | $4 |
| Hydroxyzine | 84 | $404 | $5 |
| Cephalexin | 18 | $274 | $15 |
| Terbinafine | 13 | $168 | $13 |
| Hydrocortisone | 15 | $102 | $7 |
| Gabapentin | 12 | $92 | $8 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | None | $20 |
| 2024 | 1 | 1 | None | $31 |
| 2023 | 1 | 2 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dynavax Technologies | Heplisav-B | $20 | 1 payment
|
See the published payment
| Dynavax Technologies | Meals · 2025-02-13 | Heplisav-B | $20 |
See earlier years (2024, 2023)
2024: $31
| Sanofi Pasteur | Beyfortus | $31 | 1 payment
|
2023: $31
| Pfizer | Cibinqo | $31 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Navidea Biopharmaceuticals, Inc. · An Evaluation of the Safety of Escalating Doses of Tc 99m Tilmanocept By Intravenous Injection and A Comparison To Subcutaneous Injection in Human Immunodeficiency Virus Subjects Diagnosed With Kaposi Sarcoma · 2020 | This clinician | $22,000 |
| Navidea Biopharmaceuticals, Inc. · 2019 | This clinician | $11,000 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871668509
- Licence
- CA A45876, IN 01086233ACalifornia A45876: Current · expires 2028-04-30
- Group
- County of San Mateo · Bay Area Community Health
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A458760
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Family medicine (207Q00000X)
- Mailing address
- 250 N Shadeland Ave, Indianapolis, IN, 46219
- NPI first listed
- 2006-11-21
- NPI last updated
- 2021-07-19
- NPI record certified
- 2021-07-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1001 Potrero Avenue, San Francisco, CA, 94110